WRIST Trial Shows Clear In-Stent Restenosis Radiation Benefits - Investigator
This article was originally published in The Gray Sheet
Executive SummaryIntracoronary gamma radiation appears to be a breakthrough therapy for the treatment of even the most severe forms of diffuse in-stent restenosis, according to Ron Waksman, MD, Washington (D.C.) Hospital Center, principal investigator in a spate of studies and chairman of the Feb. 17-19 Cardiovascular Radiation Therapy III conference in Washington, D.C.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.